Neurocrine biosciences announces appointment of johanna mercier to board of directors

San diego, april 16, 2021 /prnewswire/ -- neurocrine biosciences, inc. (nasdaq: nbix) today announced the appointment of johanna mercier to its board of directors. ms. mercier is the chief commercial officer of gilead sciences, with responsibility for the global commercialization of gilead's medicines.
NBIX Ratings Summary
NBIX Quant Ranking